Commercial mortgages for pharmacies

We assist borrowers with commercial mortgages for pharmacies by sourcing the most competitive products, accessing off-market and specialist healthcare lenders, and managing the full range of criteria, valuation, and affordability challenges unique to the pharmacy sector. Our role is to position each case to lender appetite balancing experience, income security, and valuation methodology, to secure funding on sustainable, long-term terms.

Pharmacy mortgages are a specialist area of healthcare lending used to purchase, refinance, or release capital from pharmacy premises, including high-street chemists, medical-centre pharmacies, and standalone pharmaceutical outlets. Pharmacies are widely viewed by lenders as defensive, low-risk healthcare assets, particularly where income is underpinned by stable NHS contracts.

Who Uses Pharmacy Mortgages

We arrange commercial mortgages for:

• Owner-operator pharmacists purchasing or refinancing premises
• Pharmacy groups acquiring additional locations
• Limited companies or partnerships operating community pharmacies
• Investors purchasing pharmacy properties let to operators

Both independent pharmacies and multi-site operators can be considered, subject to structure, experience, and income profile.

Loan-to-Value (LTV)

Commercial mortgages for pharmacies can be available at up to 100% LTV in certain circumstances, depending on income security, borrower strength, and asset quality.

• Owner-occupied pharmacies with stable trading and strong NHS income often achieve higher leverage
• Investment pharmacies with long, secure leases can attract robust terms
• Highly specialised or restrictive layouts may be assessed more conservatively

Final loan size is driven by the lower of valuation or affordability.

Affordability and Lending Assessment

We structure affordability in line with lender methodology:

Owner-occupied pharmacies are assessed on trading performance, with lenders reviewing NHS contract income, private revenue streams, margin sustainability, and cost controls.

Investment pharmacies are assessed on rental income, with lenders applying DSCR and interest-rate stress testing.

Lenders place significant weight on the sustainability, assignability, and regulatory protection of NHS income.

Valuation Methodology

Selecting the correct valuation approach is critical. Pharmacy valuations typically follow:

• Yield-based valuations where the property is let or income-producing
• Vacant possession valuations for owner-occupied premises

Valuers consider lease terms, covenant strength, regulatory compliance, and alternative-use potential, all of which can materially affect leverage and pricing.

Interest Rates and Loan Terms

Pharmacy mortgage pricing is generally competitive due to the perceived stability of the sector. Rates and terms are influenced by:

• Loan-to-value
• Security and longevity of income
• Borrower experience and scale
• Property specification and location

Loan terms typically range from 15 to 40 years, with repayment and interest-only options available depending on lender and structure.

Commercial Mortgage Criteria Challenges

We actively manage lender concerns around:

• Dependence on NHS reimbursement mechanisms
• Regulatory compliance and contract stability
• Ownership and succession planning
• Proximity to GP surgeries and population density

Pharmacies with secure NHS contracts, compliant premises, and established trading history are viewed most favourably by lenders.

How We Add Value

As a whole-of-market commercial mortgage broker, we assist pharmacy borrowers by:

• Accessing on-market and off-market healthcare lenders
• Structuring cases around lender affordability models
• Managing valuation methodology to maximise borrowing
• Overcoming experience, income, and regulatory criteria challenges

Commercial mortgages for pharmacies offer long-term, flexible funding for pharmacy premises. When structured correctly, well-established pharmacies with secure NHS income can access exceptionally strong lending terms at high loan-to-value levels.